Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Contribution of Fibrinogen to Inflammation and Neuronal Density in Human Traumatic Brain Injury.

Jenkins DR, Craner MJ, Esiri MM, DeLuca GC.

J Neurotrauma. 2018 Oct 1;35(19):2259-2271. doi: 10.1089/neu.2017.5291. Epub 2018 Jun 7.

PMID:
29609523
2.

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.

Yates RL, Esiri MM, Palace J, Jacobs B, Perera R, DeLuca GC.

Ann Neurol. 2017 Aug;82(2):259-270. doi: 10.1002/ana.24997. Epub 2017 Aug 19.

PMID:
28719020
3.

Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Geraldes R, Esiri MM, DeLuca GC, Palace J.

Brain Pathol. 2017 Nov;27(6):707-722. doi: 10.1111/bpa.12460. Epub 2017 Mar 12. Review.

PMID:
27864848
4.

Age-dependent expression of VEGFR2 in deep brain arteries in small vessel disease, CADASIL, and healthy brains.

Ahmed-Jushuf F, Jiwa NS, Arwani AS, Foot P, Bridges LR, Kalaria RN, Esiri MM, Hainsworth AH.

Neurobiol Aging. 2016 Jun;42:110-5. doi: 10.1016/j.neurobiolaging.2016.03.002. Epub 2016 Mar 10.

PMID:
27143427
5.

Complement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and Epithelium.

Moore GR, Laule C, Leung E, Pavlova V, Morgan BP, Esiri MM.

J Neuropathol Exp Neurol. 2016 May;75(5):415-28. doi: 10.1093/jnen/nlw017. Epub 2016 Mar 19.

6.

Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.

Lee JH, Koh SQ, Guadagna S, Francis PT, Esiri MM, Chen CP, Wong PT, Dawe GS, Lai MK.

Psychopharmacology (Berl). 2016 Feb;233(4):591-8. doi: 10.1007/s00213-015-4131-7. Epub 2015 Nov 6.

PMID:
26542729
7.

Genome-wide profiling of alternative splicing in Alzheimer's disease.

Lai MK, Esiri MM, Tan MG.

Genom Data. 2014 Sep 7;2:290-2. doi: 10.1016/j.gdata.2014.09.002. eCollection 2014 Dec.

8.

The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent.

Yates SC, Zafar A, Rabai EM, Foxall JB, Nagy S, Morrison KE, Clarke C, Esiri MM, Christie S, Smith AD, Nagy Z.

PLoS One. 2015 Jan 27;10(1):e0114050. doi: 10.1371/journal.pone.0114050. eCollection 2015.

9.

White matter damage in dementia. Introduction.

Love S, Esiri MM.

Brain Pathol. 2015 Jan;25(1):33-4. doi: 10.1111/bpa.12222. No abstract available.

PMID:
25521174
10.

Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.

Bridges LR, Andoh J, Lawrence AJ, Khoong CHL, Poon W, Esiri MM, Markus HS, Hainsworth AH.

J Neuropathol Exp Neurol. 2014 Nov;73(11):1026-1033. doi: 10.1097/NEN.0000000000000124.

11.

Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease.

Mohamed NE, Lee JH, Francis PT, Esiri MM, Chen CP, Lai MK.

J Alzheimers Dis. 2015;44(2):431-7. doi: 10.3233/JAD-141764.

PMID:
25261450
12.

Olfactory Pathology in Central Nervous System Demyelinating Diseases.

DeLuca GC, Joseph A, George J, Yates RL, Hamard M, Hofer M, Esiri MM.

Brain Pathol. 2015 Sep;25(5):543-51. doi: 10.1111/bpa.12209. Epub 2014 Oct 30.

PMID:
25230202
13.

The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.

Yates RL, Esiri MM, Palace J, Mittal A, DeLuca GC.

Neuropathol Appl Neurobiol. 2015 Apr;41(3):371-84. doi: 10.1111/nan.12165.

PMID:
24964187
14.

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.

Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, Esiri MM, Love S.

Brain. 2014 May;137(Pt 5):1524-32. doi: 10.1093/brain/awu040. Epub 2014 Mar 10.

15.

Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.

Yates SC, Zafar A, Hubbard P, Nagy S, Durant S, Bicknell R, Wilcock G, Christie S, Esiri MM, Smith AD, Nagy Z.

Acta Neuropathol Commun. 2013 May 8;1:3. doi: 10.1186/2051-5960-1-3.

16.

Subventricular zone cytoarchitecture changes in autism.

Kotagiri P, Chance SA, Szele FG, Esiri MM.

Dev Neurobiol. 2014 Jan;74(1):25-41. doi: 10.1002/dneu.22127. Epub 2013 Nov 4.

17.

Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).

Esiri MM, Joachim C, Sloan C, Christie S, Agacinski G, Bridges LR, Wilcock GK, Smith AD.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):30-5. doi: 10.1097/WAD.0b013e31829b72f1.

PMID:
23842286
18.

Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.

Barker R, Wellington D, Esiri MM, Love S.

J Cereb Blood Flow Metab. 2013 Jul;33(7):1050-7. doi: 10.1038/jcbfm.2013.46. Epub 2013 Mar 27.

19.

Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.

DeLuca GC, Alterman R, Martin JL, Mittal A, Blundell S, Bird S, Beale H, Hong LS, Esiri MM.

Brain. 2013 Apr;136(Pt 4):1025-34. doi: 10.1093/brain/awt031. Epub 2013 Mar 12.

PMID:
23485854
20.

A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

Kolasinski J, Stagg CJ, Chance SA, Deluca GC, Esiri MM, Chang EH, Palace JA, McNab JA, Jenkinson M, Miller KL, Johansen-Berg H.

Brain. 2012 Oct;135(Pt 10):2938-51. doi: 10.1093/brain/aws242.

21.

Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains.

Exley C, House E, Polwart A, Esiri MM.

J Alzheimers Dis. 2012;31(4):725-730.

PMID:
22699848
22.

Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.

Sádaba MC, Tzartos J, Paíno C, García-Villanueva M, Alvarez-Cermeño JC, Villar LM, Esiri MM.

J Neuroimmunol. 2012 Jun 15;247(1-2):86-94. doi: 10.1016/j.jneuroim.2012.03.020. Epub 2012 Apr 23.

PMID:
22531276
23.

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bódi I, King A, Hortobágyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H.

Neuropathol Appl Neurobiol. 2013 Feb;39(2):166-78. doi: 10.1111/j.1365-2990.2012.01272.x.

PMID:
22471883
24.

The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Richardson K, Stephan BC, Ince PG, Brayne C, Matthews FE, Esiri MM.

Curr Alzheimer Res. 2012 Jul;9(6):687-96.

PMID:
22471870
25.

Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia.

Guadagna S, Esiri MM, Williams RJ, Francis PT.

Neurobiol Aging. 2012 Dec;33(12):2798-806. doi: 10.1016/j.neurobiolaging.2012.01.015. Epub 2012 Mar 3.

PMID:
22382406
26.

Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease.

Esiri MM, Chance SA.

Alzheimers Res Ther. 2012 Mar 1;4(2):7. doi: 10.1186/alzrt105.

27.

Prefrontal cortex cytoarchitecture in normal aging and Alzheimer's disease: a relationship with IQ.

van Veluw SJ, Sawyer EK, Clover L, Cousijn H, De Jager C, Esiri MM, Chance SA.

Brain Struct Funct. 2012 Oct;217(4):797-808. doi: 10.1007/s00429-012-0381-x. Epub 2012 Feb 3.

PMID:
22302432
28.

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?

Li G, Esiri MM, Ansorge O, DeLuca GC.

J Neuroinflammation. 2012 Jan 24;9:20. doi: 10.1186/1742-2094-9-20.

29.

Sequestration and microvascular congestion are associated with coma in human cerebral malaria.

Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, Esiri MM, Day NP, White NJ, Turner GD.

J Infect Dis. 2012 Feb 15;205(4):663-71. doi: 10.1093/infdis/jir812. Epub 2011 Dec 29. Erratum in: J Infect Dis. 2012 Nov;206(9):1483.

30.

Neuropathologic evidence of endothelial changes in cerebral small vessel disease.

Giwa MO, Williams J, Elderfield K, Jiwa NS, Bridges LR, Kalaria RN, Markus HS, Esiri MM, Hainsworth AH.

Neurology. 2012 Jan 17;78(3):167-74. doi: 10.1212/WNL.0b013e3182407968. Epub 2011 Dec 14.

PMID:
22170884
31.

TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.

Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, Yusuf I, Amin H, DuPlessis D, Troakes C, Al-Sarraj S, Sloan C, Esiri MM, Prasher VP, Allsop D, Neary D, Pickering-Brown SM, Snowden JS, Mann DM.

Acta Neuropathol. 2011 Dec;122(6):703-13. doi: 10.1007/s00401-011-0879-y. Epub 2011 Oct 4.

PMID:
21968532
32.

Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner.

Miller KL, Stagg CJ, Douaud G, Jbabdi S, Smith SM, Behrens TEJ, Jenkinson M, Chance SA, Esiri MM, Voets NL, Jenkinson N, Aziz TZ, Turner MR, Johansen-Berg H, McNab JA.

Neuroimage. 2011 Jul 1;57(1):167-181. doi: 10.1016/j.neuroimage.2011.03.070. Epub 2011 Apr 5.

33.

Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease.

Mohamed NE, Zhao Y, Lee JH, Tan MG, Esiri MM, Wilcock GK, Smith AD, Wong PT, Chen CP, Lai MK.

Neurochem Int. 2011 Jun;58(7):820-5. doi: 10.1016/j.neuint.2011.03.010. Epub 2011 Mar 23.

PMID:
21419184
34.

IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain.

Tzartos JS, Craner MJ, Friese MA, Jakobsen KB, Newcombe J, Esiri MM, Fugger L.

Am J Pathol. 2011 Feb;178(2):794-802. doi: 10.1016/j.ajpath.2010.10.043.

35.

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.

Chance SA, Clover L, Cousijn H, Currah L, Pettingill R, Esiri MM.

Cereb Cortex. 2011 Aug;21(8):1870-8. doi: 10.1093/cercor/bhq264. Epub 2011 Jan 14.

PMID:
21239393
36.

Optic neuropathy in superficial intracranial siderosis.

Painter SL, Mathew L, Quaghebeur G, Esiri MM, Elston JS.

J Neuroophthalmol. 2010 Dec;30(4):311-4. doi: 10.1097/WNO.0b013e3181e92c80.

PMID:
21107121
37.

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.

Lee JH, Agacinski G, Williams JH, Wilcock GK, Esiri MM, Francis PT, Wong PT, Chen CP, Lai MK.

Neurochem Int. 2010 Dec;57(8):985-9. doi: 10.1016/j.neuint.2010.10.010. Epub 2010 Oct 27.

PMID:
21034788
38.

Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia.

Lai MK, Chen CP, Hope T, Esiri MM.

Neuroreport. 2010 Dec 8;21(17):1111-5. doi: 10.1097/WNR.0b013e3283407204.

PMID:
20890229
39.

Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

Lai MK, Tsang SW, Esiri MM, Francis PT, Wong PT, Chen CP.

Psychopharmacology (Berl). 2011 Feb;213(2-3):431-9. doi: 10.1007/s00213-010-1936-2. Epub 2010 Jul 13.

PMID:
20625884
40.

Pro: Can neuropathology really confirm the exact diagnosis?

Esiri MM.

Alzheimers Res Ther. 2010 May 7;2(2):10. doi: 10.1186/alzrt33.

41.

Ischemic stroke in the elderly: an overview of evidence.

Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM.

Nat Rev Neurol. 2010 May;6(5):256-65. doi: 10.1038/nrneurol.2010.36. Epub 2010 Apr 6. Review.

PMID:
20368741
42.

Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.

Pomeroy IM, Jordan EK, Frank JA, Matthews PM, Esiri MM.

Mult Scler. 2010 May;16(5):537-48. doi: 10.1177/1352458509360362. Epub 2010 Mar 1.

43.

Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease.

Tan MG, Chua WT, Esiri MM, Smith AD, Vinters HV, Lai MK.

J Neurosci Res. 2010 May 1;88(6):1157-69. doi: 10.1002/jnr.22290.

PMID:
19937809
44.

MS: is it one disease?

Esiri MM.

Int MS J. 2009 Jun;16(2):39-41.

PMID:
19671366
45.

T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.

Harkiolaki M, Holmes SL, Svendsen P, Gregersen JW, Jensen LT, McMahon R, Friese MA, van Boxel G, Etzensperger R, Tzartos JS, Kranc K, Sainsbury S, Harlos K, Mellins ED, Palace J, Esiri MM, van der Merwe PA, Jones EY, Fugger L.

Immunity. 2009 Mar 20;30(3):348-57. doi: 10.1016/j.immuni.2009.01.009. Erratum in: Immunity. 2009 Apr;30(4):610.

46.

Spinal cord neuronal pathology in multiple sclerosis.

Gilmore CP, DeLuca GC, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N.

Brain Pathol. 2009 Oct;19(4):642-9. doi: 10.1111/j.1750-3639.2008.00228.x. Epub 2008 Dec 19.

PMID:
19170682
47.

Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology.

Lai MK, Tan MG, Kirvell S, Hobbs C, Lee J, Esiri MM, Chen CP, Francis PT.

J Neural Transm (Vienna). 2008 Aug;115(8):1165-72. doi: 10.1007/s00702-008-0067-y. Epub 2008 May 28.

PMID:
18506388
48.

Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

Pomeroy IM, Jordan EK, Frank JA, Matthews PM, Esiri MM.

Neurosci Lett. 2008 May 30;437(2):121-4. doi: 10.1016/j.neulet.2008.03.069. Epub 2008 Mar 28.

49.

Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis.

Tsang SW, Francis PT, Esiri MM, Wong PT, Chen CP, Lai MK.

Psychopharmacology (Berl). 2008 Jun;198(2):251-9. doi: 10.1007/s00213-008-1124-9. Epub 2008 Mar 30.

PMID:
18373228
50.

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.

Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L.

Am J Pathol. 2008 Jan;172(1):146-55. Epub 2007 Dec 21.

Supplemental Content

Loading ...
Support Center